secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2026-09-21T13:12:01+00:00
Accession:  0001493152-26-043488
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD amends warrants, potential $11M proceeds tied to anticipated FDA approval of CGuard Prime 80 cm
--------------------------------------------------------------------------------

- Amended Series J (4.8M shares) and Series K (9.5M shares) warrants; exercise price for amended portion set at $0.7674.
- Potential gross proceeds up to $11M if exercised; no additional warrants issued.
- Termination date changed to May 15, 2028 or 20 trading days after FDA approval announcement; approval expected Q4 2026.
- Unchanged Series J half retains $1.3827 exercise price and SwitchGuard trigger.
- CGuard Prime 80 cm shows 100% acute success, zero MAEs at 30 days in 36-patient study; TCAR market doubles addressable opportunity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000149315226043488/0001493152-26-043488-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000149315226043488/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-043488

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer